Yamanaka R - Search Results

1

Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients.

Kawaguchi A, Yajima N, Komohara Y, Aoki H, Tsuchiya N, Homma J, Sano M, Natsumeda M, Uzuka T, Saitoh A, Takahashi H, Sakai Y, Takahashi H, Fujii Y, Kakuma T, Yamanaka R. Kawaguchi A, et al. Among authors: yamanaka r. Int J Oncol. 2012 Mar;40(3):721-30. doi: 10.3892/ijo.2011.1240. Epub 2011 Oct 21. Int J Oncol. 2012. PMID: 22021018

2

Cytokine gene expression on glioma cell lines and specimens.

Yamanaka R, Tanaka R, Saitoh T, Okoshi S. Yamanaka R, et al. J Neurooncol. 1994;21(3):243-7. doi: 10.1007/BF01063773. J Neurooncol. 1994. PMID: 7699419

3

Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.

Yamanaka R, Tanaka R, Yoshida S, Saitoh T, Fujita K. Yamanaka R, et al. J Neurooncol. 1995;25(1):59-65. doi: 10.1007/BF01054723. J Neurooncol. 1995. PMID: 8523090

4

Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.

Yamanaka R, Zullo SA, Ramsey J, Yajima N, Tsuchiya N, Tanaka R, Blaese M, Xanthopoulos KG. Yamanaka R, et al. J Neurosurg. 2002 Sep;97(3):611-8. doi: 10.3171/jns.2002.97.3.0611. J Neurosurg. 2002. PMID: 12296646

5

Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.

Yamanaka R, Yajima N, Tsuchiya N, Honma J, Tanaka R, Ramsey J, Blaese M, Xanthopoulos KG. Yamanaka R, et al. J Neurosurg. 2002 Nov;97(5):1184-90. doi: 10.3171/jns.2002.97.5.1184. J Neurosurg. 2002. PMID: 12450042

6

Dendritic cell-based glioma immunotherapy (review).

Yamanaka R, Yajima N, Abe T, Tsuchiya N, Homma J, Narita M, Takahashi M, Tanaka R. Yamanaka R, et al. Int J Oncol. 2003 Jul;23(1):5-15. Int J Oncol. 2003. PMID: 12792771 Review.

7

Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.

Kobayashi T, Yamanaka R, Homma J, Tsuchiya N, Yajima N, Yoshida S, Tanaka R. Kobayashi T, et al. Among authors: yamanaka r. Cancer Immunol Immunother. 2003 Oct;52(10):632-7. doi: 10.1007/s00262-003-0408-5. Epub 2003 Jun 21. Cancer Immunol Immunother. 2003. PMID: 12827308 Free PMC article.

8

Selection of surrogate marker genes in primary central nervous system lymphomas for radio-chemotherapy by DNA array analysis of gene expression profiles.

Yamanaka R, Akutagawa S, Taguchi F, Yajima N, Tsuchiya N, Uzuka T, Morii K, Takahashi H, Tanaka R, Saijo N, Nishio K. Yamanaka R, et al. Int J Oncol. 2003 Oct;23(4):913-23. Int J Oncol. 2003. PMID: 12963969

9

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial.

Yamanaka R, Abe T, Yajima N, Tsuchiya N, Homma J, Kobayashi T, Narita M, Takahashi M, Tanaka R. Yamanaka R, et al. Br J Cancer. 2003 Oct 6;89(7):1172-9. doi: 10.1038/sj.bjc.6601268. Br J Cancer. 2003. PMID: 14520441 Free PMC article. Clinical Trial.

10

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12.

Yamanaka R, Tsuchiya N, Yajima N, Honma J, Hasegawa H, Tanaka R, Ramsey J, Blaese RM, Xanthopoulos KG. Yamanaka R, et al. J Neurosurg. 2003 Oct;99(4):746-53. doi: 10.3171/jns.2003.99.4.0746. J Neurosurg. 2003. PMID: 14567611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters